Whole-transcriptome sequencing analysis reveal mechanisms of Yiqi Huoxue Yangyin (YHY) decoction in ameliorating D-gal-induced cardiac aging

Xue Wang, Jiaqi Zhang, Chengkui Xiu, Jing Yang, Yiqing Liu, Yan LeiAging 2023 · DOI

This paper, published in the journal AGING, explores how a Traditional Chinese Medicine (TCM) formula called Yiqi Huoxue Yangyin (YHY) decoction combats cardiac aging at a molecular level. By using whole-transcriptome sequencing, the researchers mapped out a complex regulatory network of coding and non-coding RNAs that suggest YHY works primarily by modulating the immune system and key survival signaling pathways in the heart.

TL;DR

Researchers demonstrated that YHY decoction significantly reverses structural and molecular signs of cardiac aging in mice. The study reveals that YHY exerts its effects through a "ceRNA network"—a complex interplay where non-coding RNAs act as sponges to regulate gene expression—targeting the immune system and the PI3K-Akt and MAPK signaling pathways.

What Problem Does This Paper Address?

Aging is the primary risk factor for cardiovascular disease, leading to structural changes like myocardial fibrosis (scarring) and functional decline. While Traditional Chinese Medicine, specifically the YHY decoction, has been used clinically to treat cardiovascular issues, its underlying molecular mechanisms have remained a "black box."

The authors sought to bridge this gap by moving beyond single-gene studies. They aimed to provide a holistic view of how YHY affects the "whole transcriptome"—the complete set of RNA molecules in the heart—to understand how a multi-component herbal formula can have such broad systemic effects.

Methods

The researchers used a D-galactose (D-gal) induced aging mouse model, which mimics natural aging through oxidative stress.

  • Chemical Profiling: They used High-Performance Liquid Chromatography (HPLC) to identify the active compounds in YHY, such as ferulic acid and various ginsenosides.
  • Phenotypic Validation: Heart health was evaluated via HE and Masson staining (to see tissue structure and scarring) and by measuring aging markers like telomere length, telomerase activity, p53 (a senescence marker), and Advanced Glycation End-products (AGEs).
  • Whole-Transcriptome Sequencing: This is the study's core technical contribution. They sequenced four types of RNA: mRNA (coding), and three types of non-coding RNA (lncRNA, miRNA, and circRNA).
  • Bioinformatics: They constructed a competing endogenous RNA (ceRNA) network. This model assumes that lncRNAs and circRNAs "compete" for the same microRNAs (miRNAs), thereby preventing those miRNAs from silencing their target mRNAs.

Datasets

The study generated its own primary transcriptomic datasets from mouse myocardial tissue across three groups: Control (CH), Model/Aging (MH), and YHY-treated (ZH). For analysis and target prediction, they utilized several established bioinformatics databases:

  • TargetScan & Miranda: For predicting miRNA-mRNA and miRNA-ncRNA interactions.
  • STRING: For protein-protein interaction (PPI) mapping.
  • KEGG & GO: For pathway and functional enrichment analysis.
  • MsigDB: For Gene Set Enrichment Analysis (GSEA).

Key Insights and Ideas

  • The Power of the "Sponge": The most significant insight is the identification of a ceRNA network where miR-770, miR-324, and miR-365 sit at the center. These miRNAs act as hubs; by regulating them, YHY can simultaneously influence dozens of downstream genes involved in heart health.
  • Inflammaging is Central: Both the GSEA and KEGG analyses pointed heavily toward the immune system. This suggests that YHY doesn't just "fix" heart cells directly; it likely mitigates "inflammaging"—the chronic, low-grade inflammation that drives age-related tissue decay.
  • Multi-Target Synergy: Unlike pharmaceutical drugs that usually target one receptor, YHY appears to hit multiple pathways at once, specifically PI3K-Akt (cell survival) and MAPK (stress response), providing a more robust defense against the complex process of aging.

Key Results

  • Structural Recovery: YHY treatment reduced myocardial fiber rupture and significantly lowered collagen deposition (fibrosis) compared to the aging model group.
  • Molecular Rejuvenation: YHY-treated mice showed significantly increased telomere length and telomerase activity, effectively "turning back the clock" on cellular aging markers. It also reduced p53 and AGEs expression.
  • Transcriptomic Shift: Sequencing identified 433 mRNAs, 284 lncRNAs, 62 miRNAs, and 39 circRNAs that were significantly altered by YHY treatment.
  • Pathway Enrichment: The differentially expressed genes were most significantly involved in cytokine-cytokine receptor interaction, cell adhesion molecules, and the hematopoietic cell lineage.

Limitations and Future Work

The authors acknowledge several limitations:

  1. Validation Gap: While the ceRNA network was predicted using robust bioinformatics, the specific "sponging" relationships between the identified lncRNAs and miRNAs have not yet been verified through "wet lab" experiments (like luciferase reporter assays).
  2. Tissue Heterogeneity: The sequencing was performed on whole heart tissue. This means the data blends signals from cardiomyocytes, fibroblasts, and immune cells. The authors suggest that single-cell sequencing is the necessary next step to see which specific cell types YHY is targeting.
  3. Sample Size: The study used a relatively small sample size for the sequencing portion, which may affect the statistical generalizability of the RNA network.

Summary updated

Abstract

In conclusion, our results evaluated the ceRNA network of YHY decoction in treating cardiac aging for the first time, which could provide better understanding of the potential mechanism of YHY decoction treatment of cardiac aging.
BibTeX
@inproceedings{wang2023whole,
  author = {Xue Wang and Jiaqi Zhang and Chengkui Xiu and Jing Yang and Yiqing Liu and Yan Lei},
  title = {{Whole-transcriptome sequencing analysis reveal mechanisms of Yiqi Huoxue Yangyin (YHY) decoction in ameliorating D-gal-induced cardiac aging}},
  booktitle = {Aging},
  year = {2023},
  doi = {10.18632/aging.204532},
}
Figure